Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Tubulis Raises €308M (USD 361M) in Series C Led by Venrock Healthcare Capital Partners
Series CVenture Capital

Tubulis Raises €308M (USD 361M) in Series C Led by Venrock Healthcare Capital Partners

•October 15, 2025
•Oct 15, 2025
0

Participants

Tubulis

Tubulis

company

Venrock

Venrock

investor

Wellington Management

Wellington Management

investor

Ascenta

Ascenta

investor

Nextech Invest

Nextech Invest

investor

Frazier Life Sciences

Frazier Life Sciences

investor

Andera Partners

Andera Partners

investor

Deep Track Capital

Deep Track Capital

investor

Bayern Kapital

Bayern Kapital

investor

Fund+

Fund+

investor

Hi Tec

Hi Tec

investor

EQT

EQT

investor

Deal Summary

Munich-based oncology company Tubulis closed a €308 million (USD 361M) Series C round led by Venrock Healthcare Capital Partners, with participation from new investors Wellington Management and Ascenta Capital and existing backers including Nextech Invest, EQT Life Sciences, Frazier Life Sciences and others.

0

Comments

Want to join the conversation?

Loading comments...